Phase II Trial of Imatinib Mesylate Maintenance Therapy in Patients With C-Kit (+) Extensive-Stage Small Cell Lung Cancer.

Trial Profile

Phase II Trial of Imatinib Mesylate Maintenance Therapy in Patients With C-Kit (+) Extensive-Stage Small Cell Lung Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Aug 2012

At a glance

  • Drugs Cisplatin; Imatinib; Irinotecan
  • Indications Small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Aug 2012 Company added in association field as reported by ClinicalTrials.gov.
    • 13 Mar 2012 Actual end date changed from Oct 2007 to Jan 2008 as reported by ClinicalTrials.gov.
    • 20 Apr 2010 Actual initiation date (Feb 2002) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top